Another Regenexx Research Paper accepted at the Orthopedic Research Society
We are pleased to announce the acceptance for presentation of another Regenexx Research Paper at the Orthopedic Research Society this coming January. The paper is entitled: Safety and Complications Reporting Update on the Re-Implantation of Culture-Expanded Mesenchymal Stem Cells Using Autologous Platelet Lysate Technique. This is a 4 year study of 339 patients showing that the complications from stem cell injections (Regenexx-C) were far lower than those experienced by patients undergoing traditional orthopedic surgeries such as knee replacement. Knee outcome data will also be presented. This follows our presentation at ORS on orthopedic stem cells last year. We’re proud that the Centeno-Schultz clinic has again been chosen by the prestigious research organization to present our clinic’s data on this promising technique!
If you have questions or comments about this blog post, please email us at [email protected]
NOTE: This blog post provides general information to help the reader better understand regenerative medicine, musculoskeletal health, and related subjects. All content provided in this blog, website, or any linked materials, including text, graphics, images, patient profiles, outcomes, and information, are not intended and should not be considered or used as a substitute for medical advice, diagnosis, or treatment. Please always consult with a professional and certified healthcare provider to discuss if a treatment is right for you.